Net Cash Provided by (Used in) Financing Activities in USD of Unity Biotechnology, Inc. from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Unity Biotechnology, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2016 to 2024.
  • Unity Biotechnology, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Unity Biotechnology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $77K.
  • Unity Biotechnology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$16.3M, a 129% decline from 2022.
  • Unity Biotechnology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $56.2M, a 170% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Unity Biotechnology, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 -$274K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $274K -$4.06M -93.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $4.33M -$5.73M -57% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $10.1M +$1.07M +11.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $8.99M +$8.71M +3089% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $282K -$54.1M -99.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $54.4M +$46.4M +581% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $7.99M Jan 1, 2017 Mar 31, 2017 10-Q 2018-06-07

Unity Biotechnology, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $77K +$16.4M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 -$16.3M -$72.6M -129% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
2022 $56.2M +$35.4M +170% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-07
2021 $20.8M -$43M -67.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-04-15
2020 $63.9M +$36.4M +133% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 $27.4M -$109M -80% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $137M +$94.2M +220% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
2017 $42.8M -$65.2M -60.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2016 $108M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.